{
    "Question": "Surfix Diagnostics CES 2024 product highlight and specification",
    "Summary": "Surfix Diagnostics\n\nCES 2024 Photonic Diagnostics Platform\n\n- Develops easy-to-use, reliable, and sensitive tests for early cancer detection and monitoring\n- Diagnostic tests based on liquid biopsy samples for early detection and monitoring of cancer\n- Photonic diagnostics platform combines six state-of-the-art technologies for immunoassays and molecular diagnostics\n- Utilizes photonic biosensor with proprietary nanocoatings in combination with a dedicated desktop reader\n- Aims to improve survival and quality of life for cancer patients while reducing healthcare costs\n- Contact: Agro Business Park 2, 6708 PW Wageningen (NL), +31 (0) 85 488 1285, info@surfixdx.com",
    "Summary_cn": "Surfix诊断\n\nCES 2024光子诊断平台\n\n- 开发易于使用、可靠和敏感的癌症早期检测和监测测试\n- 基于液体活检样本的早期癌症检测和监测的诊断测试\n- 光子诊断平台结合了六种最先进的技术，用于免疫分析和分子诊断\n- 利用具有专有纳米涂层的光子生物传感器与专用的台式阅读器相结合\n- 旨在提高癌症患者的生存率和生活质量，同时降低医疗保健成本\n- 联系方式：Agro Business Park 2，6708 PW Wageningen（荷兰），+31（0）85 488 1285，info@surfixdx.com"
}